Search

Search Constraints

You searched for: Author/Creator Welsing, Paco M J

Search Results

2. Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis. Issue 1 (29th August 2018)

3. Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Issue 12 (7th September 2018)

4. Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers. Issue 7 (28th July 2020)

5. Diagnostic issues in difficult-to-treat rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of difficult-to-treat rheumatoid arthritis. Issue 1 (29th January 2021)

7. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial. Issue 10042 (23rd July 2016)

8. Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy. Issue 4 (7th February 2020)

9. Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate. (20th December 2019)

10. EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Issue 1 (18th August 2021)